Despite significant progress in treating cystic fibrosis, infections remain a serious threat to the health of people living with the disease, and many rely on antibiotics as part of their regular treatment regimen. But with antibiotic-resistant infections on the rise and few drugmakers investing in research or development to bring new options to market, there simply aren’t enough antibiotics available to meet the challenges that lie ahead.

The PASTEUR Act is a critical step forward in our efforts to address the antimicrobial resistance crisis. This bipartisan bill will incentivize the development of urgently needed antibiotics and antifungals while implementing standards to use these critical medications more efficiently.

The CF community was instrumental in driving the PASTEUR Act forward in the last Congress – and we aren’t done yet. Your stories are essential and will be the reason why we make it over the finish line to pass PASTEUR this year.